Comparison of a UL111a real‐time PCR and pp65 antigenemia for the detection of cytomegalovirus
暂无分享,去创建一个
[1] C. Kotton. Management of cytomegalovirus infection in solid organ transplantation , 2010, Nature Reviews Nephrology.
[2] H. Hirsch,et al. Viral impact on long-term kidney graft function. , 2010, Infectious disease clinics of North America.
[3] K. St. George,et al. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[4] I. Binet,et al. Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients , 2008, Journal of Translational Medicine.
[5] C. Mengelle,et al. Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay. , 2007, Journal of virological methods.
[6] Hans H Hirsch,et al. Viral dynamics in transplant patients: implications for disease. , 2007, The Lancet. Infectious diseases.
[7] A. Lankester,et al. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning , 2007, European journal of haematology.
[8] L. Folgueira,et al. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients. , 2005, Transplantation proceedings.
[9] J. Córdoba,et al. Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients. , 2005, Transplantation proceedings.
[10] D. Saitovitch,et al. Cytomegalovirus disease latent and active infection rates during the first trimester after kidney transplantation. , 2004, Transplantation proceedings.
[11] E. Claas,et al. Validation of Clinical Application of Cytomegalovirus Plasma DNA Load Measurement and Definition of Treatment Criteria by Analysis of Correlation to Antigen Detection , 2004, Journal of Clinical Microbiology.
[12] T. Stevens-Ayers,et al. Optimization of Quantitative Detection of Cytomegalovirus DNA in Plasma by Real-Time PCR , 2004, Journal of Clinical Microbiology.
[13] F. Baldanti,et al. Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial. , 2003, Blood.
[14] C. Rouzioux,et al. Monitoring Cytomegalovirus Infection in Adult and Pediatric Bone Marrow Transplant Recipients by a Real-Time PCR Assay Performed with Blood Plasma , 2003, Journal of Clinical Microbiology.
[15] P. Wright,et al. Measurement of Human Cytomegalovirus Loads by Quantitative Real-Time PCR for Monitoring Clinical Intervention in Transplant Recipients , 2003, Journal of Clinical Microbiology.
[16] Thomas F. Smith,et al. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. , 2002, Transplantation.
[17] Thomas F. Smith,et al. Role of the Laboratory in Diagnosis and Management of Cytomegalovirus Infection in Hematopoietic Stem Cell and Solid-Organ Transplant Recipients , 2002, Journal of Clinical Microbiology.
[18] M. Wills,et al. Latency and reactivation of human cytomegalovirus. , 2002, The Journal of infection.
[19] J. Bourhis,et al. Quantification of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients by Real-Time PCR , 2001, Journal of Clinical Microbiology.
[20] M. Lappalainen,et al. Comparison of plasma polymerase chain reaction and pp65-antigenemia assay in the quantification of cytomegalovirus in liver and kidney transplant patients. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[21] M. Mihatsch,et al. CYTOMEGALOVIRUS INFECTION AND GRAFT REJECTION IN RENAL TRANSPLANTATION , 2001, Transplantation.
[22] J. Nicolas,et al. Quantification of Human Cytomegalovirus DNA by Real-Time PCR , 2001, Journal of Clinical Microbiology.
[23] S. Ogawa,et al. Real-Time Automated PCR for Early Diagnosis and Monitoring of Cytomegalovirus Infection after Bone Marrow Transplantation , 2000, Journal of Clinical Microbiology.
[24] M. Boeckh,et al. Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications , 1998, Clinical Microbiology Reviews.
[25] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[26] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[27] R. Razonable,et al. Viral infections in transplant recipients. , 2009, Minerva medica.
[28] 和昭 薬師寺. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation : comparison of an antigenemia assay and quantitative real-time polymerase chain reaction , 2005 .
[29] N. Kinukawa,et al. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction , 2002, Bone Marrow Transplantation.
[30] M. van der Giessen,et al. Cytomegalovirus antigenemia. , 1990, Reviews of infectious diseases.